Mimedx (MDXG) Sales of Property, Plant and Equipment (2022)
Analysis
Mimedx (MDXG) Sales of Property, Plant and Equipment (2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | - |
| 10 | Mimedx | 670.99 Mn | 535.15 Mn | 44.38 Mn | - |